Genomic Approaches to Hypertension.

Area of Science:

• Genetics
• Genomics
• Precision Medicine

Background:

• Genomic insights from Mendelian hypertension syndromes and Genome-Wide Association Studies (GWAS) enhance understanding of hypertension's genetic origins.
• Mendelian hypertension syndromes provide specific insights into disease pathogenesis and the potential for precision medicine.
• Findings on essential hypertension are evolving, refining strategies to address the societal impact of hypertension.

Purpose of the Study:

• To comprehensively identify genomic variants associated with hypertension.
• To elucidate the individual mechanisms linked to these genomic variants.
• To advance the era of personalized medicine for hypertension treatment.

Main Methods:

• Analysis of genomic insights from Mendelian hypertension syndromes.
• Genome-Wide Association Studies (GWAS) on essential hypertension.
• Comprehensive identification of genomic variants and their associated mechanisms.

Main Results:

• Genomic studies have deepened the understanding of hypertension's genetic basis.
• Knowledge of Mendelian syndromes offers specific insights into pathogenesis and precision medicine.
• Evolving clinical impact of essential hypertension findings refines efforts against its societal burden.

Conclusions:

• Comprehensive identification of hypertension's genomic variants and mechanisms is crucial for personalized medicine.
• Reducing health inequities requires improved compliance and implementation science incorporating genomic medicine.
• Genomic medicine holds promise for refining hypertension management and reducing its societal impact.